Elizabeth White
Chief Operating Officer presso RENOVACOR, INC.
Posizioni attive di Elizabeth White
Società | Posizione | Inizio | Fine |
---|---|---|---|
RENOVACOR, INC. | Chief Operating Officer | - | - |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Chief Operating Officer | 19/07/2021 | - |
Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy Miscellaneous Commercial ServicesCommercial Services Parent Project Muscular Dystrophy focuses on finding a cure for Duchenne muscular dystrophy. The company was founded by Pat Furlong in 1984 and is headquartered in Washington, DC. | Director/Board Member | - | - |
Storia della carriera di Elizabeth White
Formazione di Elizabeth White
Rochester Christian University | Doctorate Degree |
Allegheny College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Chief Operating Officer | 2 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy Miscellaneous Commercial ServicesCommercial Services Parent Project Muscular Dystrophy focuses on finding a cure for Duchenne muscular dystrophy. The company was founded by Pat Furlong in 1984 and is headquartered in Washington, DC. | Commercial Services |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Health Technology |
Renovacor, Inc.
Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Elizabeth White
- Esperienza